Somewhat Positive News Coverage Somewhat Unlikely to Affect Tenet Healthcare (THC) Stock Price
Press coverage about Tenet Healthcare (NYSE:THC) has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Tenet Healthcare earned a coverage optimism score of 0.12 on Accern’s scale. Accern also gave headlines about the company an impact score of 46.3113695033729 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Here are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:
- Zacks: Analysts Anticipate Tenet Healthcare Corporation (THC) Will Announce Earnings of $1.29 Per Share (americanbankingnews.com)
- Houston has a new No. 1 health care system by bed count due to acquisitions (bizjournals.com)
- Critical Review: Tenet Healthcare (THC) versus American Renal Associates (ARA) (americanbankingnews.com)
- "Fast Money" final trades: ETFC, NKE and more (finance.yahoo.com)
- Tenet to Participate in the Bank of America Merrill Lynch Leveraged … – Business Wire (press release) (businesswire.com)
A number of brokerages recently commented on THC. Robert W. Baird restated a “buy” rating and set a $23.00 price objective on shares of Tenet Healthcare in a research note on Thursday, August 24th. Citigroup reissued a “hold” rating and issued a $16.00 price target on shares of Tenet Healthcare in a research note on Thursday, September 14th. Royal Bank Of Canada reissued a “hold” rating and issued a $19.00 price target on shares of Tenet Healthcare in a research note on Monday, September 25th. Mizuho reissued a “neutral” rating and issued a $14.00 price target on shares of Tenet Healthcare in a research note on Sunday, August 20th. Finally, Credit Suisse Group started coverage on Tenet Healthcare in a research note on Thursday, November 2nd. They issued a “neutral” rating and a $15.00 price target for the company. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and six have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $19.00.
Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Monday, November 6th. The company reported ($0.17) earnings per share for the quarter, beating the consensus estimate of ($0.40) by $0.23. The firm had revenue of $4.59 billion for the quarter, compared to analyst estimates of $4.94 billion. Tenet Healthcare had a negative return on equity of 5.61% and a negative net margin of 2.85%. Tenet Healthcare’s quarterly revenue was down 5.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.16 earnings per share. equities research analysts anticipate that Tenet Healthcare will post 0.69 earnings per share for the current fiscal year.
Tenet Healthcare Company Profile
Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital.
Receive News & Stock Ratings for Tenet Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare Corporation and related stocks with our FREE daily email newsletter.